Hemab initiates phase 3 trial for rare bleeding disorder drug

🌐 Investing.com (Cyprus) —
Hemab initiates phase 3 trial for rare bleeding disorder drug

AI Summary

Hemab initiated a Phase 3 clinical trial for a drug targeting a rare bleeding disorder. The headline does not name the drug or provide details about the trial's design or enrollment.

Health Hemab Phase 3 clinical trial rare disease bleeding disorder drug development

Read original source →